Dataset from A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Paliperidone ER Compared to Quetiapine in Subjects With an Acute Exacerbation of Schizophrenia

The purpose of this study is to evaluate the efficacy (effectiveness of drug) and safety of the antipsychotic paliperidone ER compared to another antipsychotic, quetiapine, and to placebo in patients who are acutely ill with symptoms of schizophrenia.

本研究旨在评估抗精神病药物帕利哌酮缓释剂（paliperidone ER）相较于另一款抗精神病药物喹硫平（quetiapine）以及安慰剂，在伴精神分裂症急性发作症状患者中的疗效（药物有效性）与安全性。